Death the Fas way: Regulation and pathophysiology of CD95 and its ligand

Pharmacology and Therapeutics

Volumn 88, Issue 3, 2000, Pages 333-347

  Sharma, K ^a   Wang, R X ^a   Zhang, L Y ^a   Yin, D L ^a   Luo, X Y ^a   Solomon, J C ^a   Jiang, R F ^a   Markos, K ^a   Davidson, W ^a   Scott, D W ^a   Shi, Y F ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Apoptosis; Caspase; Fas CD95; Immune responses; Ligand; TNF

Indexed keywords

CASPASE; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; LIGAND;

AGING; APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL MEMBRANE; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIGAND BINDING; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STRESS; TRANSCRIPTION REGULATION;

AGING; ANTIGENS, CD95; ANXIETY DISORDERS; APOPTOSIS; BLISTER; CELL MEMBRANE; DNA DAMAGE; FAS LIGAND PROTEIN; HIV INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASMS; PHAGOCYTOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0034450186     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00096-6     Document Type: Review

References (195)

1. Fas ligand mediates activation-induced cell death in human T lymphocytes
2. Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus
3. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
4. Elevated serum level of Fas ligand correlates with the asymptomatic stage of human immunodeficiency virus infection
5. CD95-CD95L: Can the brain learn from the immune system?
6. Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity
7. A role for CD95 ligand in preventing graft rejection
8. Controlling programmed cell death with a cyclophilin-cyclosporin-based chemical inducer of dimerization
9. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
10. The Fas-based mechanism of lymphocytotoxicity
11. Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas
12. Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
13. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment
14. Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents
15. Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy
16. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
17. Regulation of CD95 ligand expression: A key element in immune regulation?
18. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506
19. Expression of fas ligand in activated T cells is regulated by c-Myc
20. Regulation of apoptosis in thymocytes
21. T cell antigen receptor signal transduction pathways
22. T cell antigen receptor signal transduction pathways
23. Fas modulation of apoptosis during negative selection of thymocytes
24. Thymic expression of the transcription factor Nur77 rescues the T cell but not the B cell abnormality of gld/gld mice
25. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases
26. Caspases: The executioners of apoptosis
27. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells
28. Early events in TNF signaling: A story of associations and dissociations
29. Inhibition of protein tyrosine phosphatases causes phosphorylation of tyrosine-331 in the p60 TNF receptor and inactivates the receptor-associated kinase
30. The p80 TNF receptor-associated kinase (p80TRAK) associates with residues 354-397 of the p80 cytoplasmic domain: Similarity to casein kinase
31. Immunologic abnormalities of mice bearing the gld mutation suggest a common pathway for murine nonmalignant lymphoproliferative disorders with autoimmunity
32. Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions
33. Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands
34. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin
35. RAIDD is a new "death" adaptor molecule
36. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen
37. p53 and the CNS: Tumors and developmental abnormalities
38. Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity
39. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: The effect of topical Cyclosporin A therapy
40. Calcium and T lymphocyte activation
41. Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc
42. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation
43. Cardiac operations in patients with low-grade small lymphocytic malignancies
44. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B200+ double-negative T cells as the predominant populations in enlarged lymph nodes
45. The accumulation of B200+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cell or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells
46. Programmed cell death in HIV infection: Dysregulation of BCL-2 and Fas pathways and contribution to AIDS pathogenesis
47. Apoptotic pathways: The roads to ruin
48. Activation-induced apoptosis in lymphocytes
49. Fas ligand-induced apoptosis as a mechanism of immune privilege
50. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity
51. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
52. Apoptosis: Molecular regulation of cell death
53. Selection of the T cell receptor repertoire in Lpr mice
54. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis
55. Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese
56. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production
57. CD95: More than just a death factor?
58. Induction of cell death by chimeric L-selectin-Fas receptors
59. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
60. Induction of cell death via Fas (CD95, Apo-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation
61. Antigen-induced apoptosis in developing T cells: A mechanism for negative selection of the T cell receptor repertoire
62. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
63. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival
64. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
65. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
66. Physician education: Apoptosis
67. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
68. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor
69. The thymus and central tolerance
70. A role for Fas in negative selection of thymocytes in vivo
71. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice
72. Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus
73. A comparison of the cytoplasmic domains of the Fas receptor and the p75 neurotrophin receptor
74. Cross-linking of the Fas/APO-1 antigen suppresses the CD3-mediated signal transduction events in human T lymphocytes
75. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus
76. Persistent expression of a soluble form of Fas/APO1 in continuously activated T cells from a patient with SLE
77. Effect of treatments with cyclosporin A and anti-interferon-gamma antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice
78. Mutations in the Fas antigen in patients with multiple myeloma
79. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
80. Nuclear factor kappa B: Important transcription factor and therapeutic target
81. Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5
82. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77)
83. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
84. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids
85. Imbalanced cytokine production by macrophages from autoimmune-prone mice
86. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils
87. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77
88. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB
89. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
90. Differential susceptibility to anti-receptor induced apoptosis in adult murine B-cells: Role of B1 cells
91. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1
92. Molecular genetic studies in lymphocyte apoptosis and human autoimmunity
93. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia
94. The CD95 system and the death of a lymphocyte
95. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma
96. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
97. Cleavage of FLICE (caspase-8) by granzyme B during cytotoxic T lymphocyte-induced apoptosis
98. Nuclear transcription factor kappa B (NF-kappa B)
99. Fas/APO-1/CD95 in health and autoimmune disease: Thymic and peripheral aspects
100. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis
101. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
102. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo
103. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
104. Apoptosis mediated by the Fas system
105. Fas-mediated apoptosis
106. The Fas death factor
107. Fas and Fas ligand: lpr and gld mutations
108. The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity
109. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes
110. Phenotypic and functional stages in the intrathymic development of alpha beta T cells
111. A newly identified response element in the CD95 ligand promoter contributes to optimal inducibility in activated T lymphocytes
112. Activation-induced T cell death: Resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype
113. Activation-induced cell death in proliferating T cells is associated with altered tyrosine phosphorylation of TCR/CD3 subunits
114. Introduction: p53 - The first twenty years
115. Separate domains of the human fas ligand dictate self-association and receptor binding
116. Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand
117. Genetic regulation of apoptosis in the mouse thymus
118. Lymphoproliferative disorders of natural killer cells
119. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells
120. Regulatory factors in lymphoid development
121. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion
122. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death
123. Peyer's patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for tumor necrosis factor and its 55-kDa receptor
124. Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones
125. Cross-linking the TCR complex induces apoptosis in CD4+8+ thymocytes in the presence of cyclosporin A
126. The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function
127. The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis
128. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death
129. Macromolecular substrates for the ICE-like proteases during apoptosis
130. Role of metal-catalyzed oxidation reactions in the early pathogenesis of scleroderma
131. Activation-induced death of mature T cells in the regulation of immune responses
132. Two CD95 (APO-1/Fas) signaling pathways
133. Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex
134. The role of c-FLIP in modulation of CD95-induced apoptosis
135. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase
136. T cells commit suicide, but B cells are murdered!
137. Interactions of TCR tyrosine based activation motifs with tyrosine kinases
138. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes
139. Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation
140. In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes
141. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas
142. Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis
143. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation
144. The expanded populations of CD4- CD8- T cell receptor alpha/beta+ T cells associated with the lpr and gld mutations are CD2
145. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis
146. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice
147. Apoptosis, Fas and systemic autoimmunity: The MRL-lpr/lpr model
148. Novel origin of lpr and gld cells and possible implications in autoimmunity
149. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures
150. Death by design: Mechanism and control of apoptosis
151. Immune evasion by tumours: Involvement of the CD95 (APO-1/Fas) system and its clinical implications
152. Fas ligand - Caught between Scylla and Charybdis
153. An inherited disorder of lymphocyte apoptosis: The autoimmune lymphoproliferative syndrome
154. Expression of the Fas ligand in cells of T cell lineage
155. T-cell antigen receptor-induced signal-transduction pathways - Activation and function of protein kinases C in T lymphocytes
156. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR
157. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
158. Downregulation of Fas ligand by shedding
159. Apoptosis and the B cell response to antigen
160. Differential requirement of protein tyrosine kinase and protein kinase C in the generation of IL-2-induced LAK cell and alpha CD3-induced CD3-AK cell responses
161. Monoclonal antibody-mediated tumor regression by induction of apoptosis
162. Inhibition of fas death signals by FLIPs
163. The fight of viruses against apoptosis
164. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells
165. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations
166. Role of Fas-mediated cell death in the regulation of immune responses
167. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance
168. CD95 mediated T cell apoptosis and its relevance to immune deviation
169. Differential ability of T cell subsets to undergo activation-induced cell death
170. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells
171. Fas-associated death domain protein interleukin-1beta-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling
172. Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients
173. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction
174. Cell death induction by TNF: A matter of self control
175. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression
176. Protein kinase C regulates Fas (CD95/APO-1) expression
177. Apoptosis mediated by the TNF-related cytokine and receptor families
178. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
179. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway
180. Immunological and pathological consequences of mutations in both Fas and Fas ligand
181. T cell antigen receptor: Structure, assembly and function
182. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
183. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells
184. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas
185. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene
186. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease
187. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
188. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77
189. Fas-mediated cell death promoted by opioids
190. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression
191. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
192. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer
193. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1
194. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression
195. Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells